Panacea Biotec Limited has informed the Exchange about Copy of Newspaper Publication
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec Limited has informed the stock exchanges about the newspaper publication of its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The results extract was published on February 12, 2026 in two newspapers — Business Standard (English) and Desh Sewak (Punjabi). This filing is made under Regulation 47 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The financial results themselves were approved on February 11, 2026 and shared with the exchanges earlier. The letter is signed by Ankit Jain, General Manager – Legal & Company Secretary.
This is a routine regulatory compliance filing and does not contain any new financial information. Shareholders who want the detailed Q3 FY26 numbers should refer to the results filed earlier or visit the company's website and exchange portals.